Dr Khurum Khan Consultant Profile
Dr Khan is an experienced Medical Oncologist who is highly active in research and draws on his interest and experience in clinical trials data and developments in the field to inform decision making and provide patients access to the latest treatments.
He combines a holistic and personalised approach to medicine that is based just as much on the patient’s individual wishes as pathological factors. He believes that good communication is key and wants patients to feel at absolute ease throughout their care.
As an active member of multidisciplinary teams at University College London Hospital (UCLH), The Whittington Hospital and The London Clinic, Dr Khan works closely with other disciplines, including surgeons, gastroenterologists, cardiologists and interventional radiologists to support decision-making at various stages of patient care.
Dr Khan remains at the forefront of cutting-edge research focusing on new targeted therapies in cancer, immunotherapy and genomics. Leading gastrointestinal research at the Clinical Research Facility (CRF) at University College London Hospitals (UCLH) NHS Trust, his team has concentrated on druggable target discovery and at UCL cancer institute, the team’s focus remains discovery of biomarkers using liquid biopsies, patient derived organoids (PDOs) and other novel technologies.
After completing junior doctors training in various parts of the UK, Dr Khan completed his training in medical oncology at Royal Marsden NHS Trust in London before joining Royal Marsden and Kingston Hospitals as a consultant in 2017. As a consultant at Royal Marsden, Khurum contributed to the development of a new Acute Oncology Services at the Royal Marsden Hospital. He then moved to UCLH and North Middlesex University Hospital (NMUH) in 2019. As NMUH’s Clinical Lead of Carcinomas of Unknown Primary and Research Lead, Dr Khan dedicated time to improving the provision of care for patients with these cancers.Since 2022, he is working at UCLH and Whittington hospitals, leading early phase clinical trials in Gastrointestinal (GI) malignancies at CRF and working towards “UCLH at Whittington model”- a service that is expected to transform cancer care in North London. Dr Khan is best placed in delivering this service as he is GI research speciality lead at NIHR Clinical Research Network (CRN).